This Clinical Trial Could Change How Prostate Cancer Is Detected in Black Men

Preliminary clinical research findings by the University of Alberta indicate that PET/CT imaging could replace the standard MRI in the detection and prediction of the spread of prostate cancer.   The research, led by Dr. Adam Kinnaird, found PET/CT scan imaging to be more effective in determining the existence of metastasized prostate cancer cells than MRI imaging.  Kinnaird—an Assistant Professor in the Department of Surgery at the university—explained that, typically, when prostate cancer is detected, patients undergo surgery to remove the prostate, but if cancer has spread outside the prostate, surgeons will treat it beyond the initial area to ensure no cancer cells remain.  “This imaging test gives us a better degree of accuracy in terms of where exactly we need to treat,” Kinnaird explained in a press release. According to the American Cancer Society, prostate cancer is the second most common cancer in men, in the United States. However, Black men are more likely to be diagnosed with prostate cancer than their white counterparts and they are twice as likely to die from the disease.  Early Detection Prostate Cancer Screenings and Clinical Trials Mean Better Outcomes for Black Men Because they tend to be diagnosed once prostate cancer has reached...